Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV4 | Q9HBA0 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | CTSL | P07711 | 1/20 | 0.39 |
| ▸ | CTSS | P25774 | 1/20 | 0.39 |
| ▸ | PHGDH | O43175 | 12/20 | 0.38 |
| ▸ | CCR1 | P32246 | 2/20 | 0.36 |
| ▸ | F10 | P00742 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4053067 | 0.86 | TRPV4 (0.46) | TRPV4KMT2ACCR1 | |
| SCHEMBL8010542 | 0.86 | TRPV4 (0.44) | TRPV4MEN1KMT2ACTSLCTSS | |
| SCHEMBL4049334 | 0.84 | TRPV4 (0.64) | TRPV4CTSSCCR1 | |
| SCHEMBL4056496 | 0.84 | TAS1R3 (0.46) | TRPV4CTSLCTSS | |
| SCHEMBL4051572 | 0.84 | TRPV4 (0.64) | TRPV4CTSSCCR1 | |
| SCHEMBL4051481 | 0.84 | TRPV4 (0.64) | TRPV4CTSSCCR1 | |
| SCHEMBL19856860 | 0.84 | TRPV4 (0.64) | TRPV4CTSSCCR1 | |
| SCHEMBL4054443 | 0.84 | TRPV4 (0.46) | TRPV4CTSLCTSS | |
| SCHEMBL4051232 | 0.82 | TRPV4 (0.49) | TRPV4MEN1KMT2ACCR1 | |
| SCHEMBL8004208 | 0.82 | TRPV4 (0.43) | TRPV4MEN1KMT2ACTSLCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009111680-A1 | TRPV4 ANTAGONISTS | SMITHLINE BEECHAM CORPORATION (US) | 2009-09-11 | — | — | WO | claimed |
| WO-2009111680-A1 | TRPV4 ANTAGONISTS | SMITHLINE BEECHAM CORPORATION (US) | 2009-09-11 | — | — | WO | disclosed |